Drug intelligence / Profile preview

Leifengshi Yihao Wan

Development stage: Unknown
Administration: Oral

Overview

Leifengshi Yihao Wan (雷风湿一号丸, "Leifengshi No. 1 Pill") is a traditional Chinese medicine (TCM) formula promoted for the relief of symptoms associated with rheumatic and musculoskeletal conditions such as rheumatoid arthritis and osteoporosis. It is typically marketed as an herbal remedy in pill form. There is no evidence from the provided sources or major regulatory agencies that this product contains a single defined pharmaceutical ingredient; rather, it appears to be a multi-ingredient TCM formulation. Some similar products in this category have been found to contain undeclared non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac and indomethacin[1], but there is no direct evidence that Leifengshi Yihao Wan specifically contains these substances.

Brand names: Leifengshi Yihao Wan
Other names: Leifengshi No. 1 Pill雷风湿一号丸

Beyond the preview

Go deeper on Leifengshi Yihao Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leifengshi Yihao Wan.

Explore the full profile